NASDAQ$CLMT
Calumet Inc · Q4 2025 earnings
Q4 2025 earnings · · Before market open · Investor relations
Briefing
Calumet reported Q4 2025, net loss of $33.8M, diluted EPS of $-0.39.
For Q4 2025, Calumet reported a net loss of $33.8M, diluted EPS was $-0.39. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.
- Net loss $33.8M.
- Diluted EPS $-0.39.
- Calumet MD&A covers liquidity, credit, and operating priorities.
Headline financials
Revenue & EPS history
Calumet Specialty Products · Revenue · Quarterly
$1.04B
Forward guidance
The quarterly filing discusses operating priorities, capital returns, and sector risks; numeric multi-quarter bridges vary by issuer.
Tailwinds
- MD&A highlights liquidity, capital, and core business trends.
- Segment or product commentary supports the earnings narrative.
Headwinds
- Macro, rates, or input costs may pressure near-term margins.
- One-time items can affect year-over-year comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 5 quarterly earnings reports · overlaid with Q4 2025
-4.3%
Avg return
Earnings day
-2.3%
Avg return
5 days after
+6.6%
Avg return
30 days after
17%
1 / 6 earnings
Positive
+6.5%
Q1 2025
Best reaction
-10.8%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.4% | -9.3% | +1.5% | |
| Q4 2025 | -10.8% | -3.0% | +6.1% | |
| Q3 2025 | -1.6% | -3.0% | -0.9% | |
| Q2 2025 | -3.6% | -4.2% | +19.7% | |
| Q1 2025 | +6.5% | +11.4% | +14.9% | |
| Q3 2024 | -8.6% | -6.0% | -1.9% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro